News about Eli Lilly
Alex Azar was a top executive at drug giant Eli Lilly.
Novartis and Amgen want to find out with an experimental drug.
AbbVie and Alector hope to apply immunotherapy to dementia and Alzheimer's.
Goldman analysts think the drug could eventually ring in $12 billion in sales if approved.
If he pulls it off, he will make more than all of his peers combined.